Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.

Janka Ryding, L Dahlberg, M Wallen-Ohman, Joakim Dillner

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

26 !!Citations (SciVal)

Sammanfattning

Human papillomavirus type 16 (HPV-16) is a major cause of human cancer. Effective prophylactic vaccines are based on type-specific neutralizing antibodies. A major neutralizing epitope has been defined by the monoclonal antibody H16.V5. To investigate the importance of this epitope for overall immunogenicity of HPV-16, HPV-16 virus-like particles devoid of the H16.V5 epitope were engineered by site-directed mutagenesis of ten non-conserved, surface-exposed residues. Removal of the H16.V5-defined epitope had only a marginal effect on antigenic reactivity with antibodies in sera from infected subjects, but affected immunogenicity in experimental immunization of mice, with reduced induction of both antibody responses and CTL responses.
Originalspråkengelska
Sidor (från-till)792-802
TidskriftJournal of General Virology
Volym88
UtgåvaPt 3
DOI
StatusPublished - 2007

Ämnesklassifikation (UKÄ)

  • Mikrobiologi inom det medicinska området

Fingeravtryck

Utforska forskningsämnen för ”Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här